Obesity in Elderly Subjects: In sheep's clothing perhaps, but still a wolf! by Osher, Etty & Stern, Naftali
Obesity in Elderly Subjects
In sheep’s clothing perhaps, but still a wolf!
ETTY OSHER, MD
NAFTALI STERN, MD
A
lthough the negative impact of high
BMI on the risk of death from all-
cause mortality is now well estab-
lished, there is an apparent decline in the
relativeaddedriskofobesitywithincreas-
ingage(1,2).Thishasledsomeexpertsto
conclude that obesity should not neces-
sarilybeviewedasadiseaseinindividuals
older than 55 years. If such shift in the
approach to adiposity during the latter
phases of life is prematurely accepted, it
may not only discourage attempted
weight loss in older subjects, but also
promote nutritional and lifestyle indul-
gence, which is presently difﬁcult
enoughtoovercome.Itisthepurposeof
the present commentary to brieﬂy out-
line the full spectrum of obesity-related
hardshipsintheelderly.Inouropinion,
obesity-induced complications amount
to real disease, which gravely affects
quality of life and limits effective
lifespan.
OBESITY, HYPERTENSION,
DIABETES, AND THE
METABOLIC SYNDROME IN
ADVANCED AGE— The incidence
of hypertension, diabetes, and the meta-
bolic syndrome intensiﬁes with age, and
aging per se is closely linked to increased
prevalence of most of the abnormalities
contributing to the metabolic syndrome
(3). The incidence of the metabolic syn-
drome rises with increasing BMI, and a
broader waist circumference is more
common in men older than 65 years than
in younger age-groups (3). The occur-
rence of the metabolic syndrome reaches
peak levels in the 6th decade for men and
the 7th decade for women, and a decline
is noted only in the 8th decade for men
and for some women in different ethnic
groups (3). As recently outlined by the
American Heart Association Professional
Education Committee of the Council for
High Blood Pressure Research, older age
and obesity are two of the most powerful
riskfactorsforuncontrolledhypertension
(4), and high blood pressure, in turn, is a
major determinant of mortality and
stroke incidence, particularly in senior
years. BMI and abdominal obesity are sig-
niﬁcantly and independently associated
with an increase in the prevalence of type
2 diabetes and hypertension, and obesity
contributes to the development of hyper-
tension in diabetes in all ages, including
old age (5). Hence, separation of abdom-
inaladiposityfromitsclosestsequels,i.e.,
the metabolic syndrome, hypertension,
and diabetes, is somewhat artiﬁcial, espe-
cially later in life. Adiposity strongly in-
ﬂuences these risk factors, which, with
the passage of time, may directly domi-
natetheoccurrenceofcomplications.The
strongest support for such a sequence of
events is the fact that attempted weight
loss is associated with lower all-cause
mortality, regardless of age (6).
OBESITY AND MORTALITY
IN OLDER SUBJECTS— Despite
claims that obesity is not harmful in older
individuals, several large-scale studies,
such as the 10-year follow-up of the Na-
tional Institutes of Health–AARP cohort
(1), indicated that both overweight and
obesity, at all ages and in both sexes, par-
ticularly in those individuals who had
never smoked and who had no history of
disease, are linked to increased mortality
(1,2,7). Although the relative escalation
in risk associated with a high BMI may
decline with advancing age, the absolute
rise in mortality rates associated with a
high BMI is still much greater in elderly
subjects, simply due to increased death
rates in this age range (2). This relation-
ship may no longer exist for the very old,
inwhommortalityratesmaybedrivenby
malignancy or aging of the cardiovascular
tree that evolved throughout life. In this
extreme age range, body weight most
likely reﬂects both overall health status
and the process of aging-induced weight
loss. However, this cannot be extrapo-
lated to the older population at large or
viewed as evidence that high BMI is gen-
erally beneﬁcial in the 6th to the 8th de-
cades of life.
The true impact of overweight and
obesity on mortality may be obscured by
confounding factors. For example, re-
verse causation induced by preexisting
chronic disease and inadequate control
for smoking status can mask the effect of
obesity through the excessive death risk
caused by these low BMI–associated con-
ditions. In some distinct diseases of the
elderly, such as Alzheimer’s disease (8) or
Parkinsonism (9), weight loss may pre-
cede the time of diagnosis by years, thus
causing further false overrepresentation
of morbidity and mortality in the low
weight range.
Finally, cumulative attrition of the
mostvulnerablefractionoftheobesepop-
ulationbroughtaboutbyprematuremor-
talityofthosesubjectswhodonotsurvive
the late-midlife years leaves only the most
biologically advantaged obese survivors
for “nonbiased” epidemiological analysis
of obesity in advanced years. If one ac-
cepts that obesity increases mortality in
younger years, attempted comparison be-
tween age-matched obese and lean hu-
mans in the older age inevitably leads to
thestudyoftwohighlyunequalcohortsof
which only one has been subjected to the
Darwinian process of obesity-related
attrition.
HEALTH ADVANTAGES OF
OLDER OBESE SUBJECTS:
RESILIENT BONES AND THE
“OBESITY PARADOX”— Reex-
amination of the impact of obesity on
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potential beneﬁts of weight excess: de-
creased osteoporosis and better survival
of obese subjects with certain health haz-
ards, known as the “obesity paradox.”
Obesity,linkedtoincreasedbonemineral
density, is thus far uncontested, as is the
fact that this also translates into a lower
rate of hip fractures in elderly obese sub-
jects (10). The latter may reﬂect not only
greaterboneresilience,butalsoimproved
cushioning by adipose tissue during falls.
An important emerging exception to this
general protective effect of obesity on
bone is the recent ﬁnding that although
men and women with the metabolic syn-
drome do indeed enjoy better total hip
and femoral neck bone mineral density in
a cross-sectional analysis, these associa-
tionsdonottranslatetoimprovedclinical
outcome. In fact, incident clinical frac-
tures were 2.6 times more likely to occur
in subjects with the metabolic syndrome
compared with participants without the
metabolic syndrome after an average fol-
low-up of 2 years (11).
The “obesity paradox” refers to the un-
expected ﬁndings that obese subjects seem
tofarebetterthan,oratleastaswellas,their
normal- or low-weight counterparts in
terms of mortality rates in the context of
conditions, such as coronary artery disease
in hypertensive subjects, congestive heart
failure, chronic kidney disease, hemodialy-
sis, postcoronary revascularization, and
some instances of non-ST segment eleva-
tion in myocardial infarction (12,13). Cur-
rently, it is unclear whether or not all these
different situations that share some com-
mon, yet unidentiﬁed, underlying mecha-
nism are related to obesity itself, or rather
reﬂect nutritional status or reserve, and/or
possibly coexisting medical therapy. It re-
mains uncertain how older age interacts
with these protective effects of excess adi-
posity.Additionally,obesityisnotageneral
“savior”inacutemedicalconditions.Hence,
this interesting and potentially critical phe-
nomenon remains presently enigmatic, re-
quiring case- and age-speciﬁc in-depth
examination. As an example of this effect,
some 20 years ago, obesity in the elderly
was actually linked to the twofold increase
of postmyocardial infarction and in-
hospital mortality in subjects 65 years
(14). Has the obese phenotype been
changed by the environment, or chronic
medicaltherapy,orrather,haveadvancesin
the quality of critical care preferentially af-
fected the obese?
OBESITY AND
CARDIOVASCULAR DISEASE
IN THE ELDERLY — The cardiometa-
bolic complications of obesity have been
generally linked to central adiposity, but
in many reports, obesity is quantiﬁed in
terms of BMI alone, rather than waist cir-
cumference, which may potentially mask
the association of abdominal fat and car-
diovasculardiseaseandevents.Neverthe-
less, a body of evidence indicates that
obese older subjects are more prone to
cardiovascular morbidity. In the Health
Professionals’Follow-upStudy,menaged
65yearsorolder,withawaist-to-hipratio
of 0.98, had a 2.76-fold increased risk
for coronary heart disease (CHD), even
after adjustment for BMI and other car-
diac risk factors (15). In the Physicians’
Health Study (a randomized trial of aspi-
rin and -carotene among 22,071 appar-
ently healthy U.S. male physicians, aged
40–84 years at baseline), abdominal adi-
posity,whethermeasuredbywaist-to-hip
ratio or waist circumference, was associ-
ated with a modest elevation in the risk of
CHDinbothmiddle-agedandoldermen.
Ofparticularnoteinthisstudyistheﬁnd-
ing that age did not signiﬁcantly modify
the relationship between either measure
of abdominal adiposity and risk of CHD
(16). In a Chinese cohort of 67,334
women, aged 40–70 years, who had no
prior history of CHD, stroke, or cancer at
recruitment into the study, in the course
ofameanfollow-upof2.5years(168,164
person-years),waist-to-hipratiowaspos-
itively associated with the risk of CHD in
both younger and older women, while
other anthropometrics, including BMI,
wererelatedtoCHDriskprimarilyamong
younger women (17). In a prospective
study of 516 Brazilian women, aged
60–84 years, who were followed up for
an average period of 6.6 years, the pres-
ence of the metabolic syndrome and high
waist-to-hip ratio was associated with in-
creased cumulative risk (odds ratio 1.66
and1.72,respectively)ofstroke,myocar-
dial infarction, evidence of coronary ar-
terydisease,orcardiovasculardeath(18).
In the Epidemiologic Follow-Up Study of
the First National Health and Nutrition
Examination Survey (NHANES I), 1,259
Caucasian women aged 65–74 years with
BMI 29 kg/m
2 showed 50% increased
risk of CHD in the course of a mean fol-
low-upperiodof14years,whichwas2.5-
fold higher than in women with BMI of
23–24 kg/m
2 (19). A Swedish study of
70-year-old subjects, initially free from
CHD, found that the 15-year risk-
adjusted incidence of CHD was increased
by larger waist circumference and BMI in
males but not in females (20). In a U.S.
cohort of 4,968 older (65 years) men
and women from the Cardiovascular
Health Study followed up for 9 years, the
risks of myocardial infarction or stroke
did not differ in the overweight range of
25–29.99 kg/m
2, thus suggesting that a
BMI cutoff point of 25 kg/m
2 may be
overly restrictive for the elderly (21).
Overall, these data support an association
between adiposity, particularly central
adiposity, as assessed by anthropometric
measurements, and increased propensity
forcardiovasculardisease,predominantly
CHD.
OBESITY AND THE
INCIDENCE OF STROKE IN
OLDER SUBJECTS— Association
between obesity and stroke in advanced
agehasbeeninconsistentandmaybesex-
related. The Canadian Cardiovascular
Health study did not ﬁnd obesity to be a
predisposing factor for stroke in older
subjects (21). Conversely, the Honolulu
Heart Program, which over a 22-year pe-
riodprospectivelyfollowedupacohortof
1,163 nonsmoking men aged 55–68
years, found that the rate of thromboem-
bolic stroke rose signiﬁcantly with in-
creasing levels of BMI (22). In subjects
from the Framingham Offspring Study
aged 50–81 years, the 10-year popula-
tion attributable risk of stroke was greater
for the metabolic syndrome than for dia-
betes, particularly in women (27 vs. 5%),
owingtoitsgreaterprevalenceofthemet-
abolic syndrome in the general popula-
tion (23). Obesity did not affect stroke
rates in Korean men (24). A Spanish
stroke registry of 2,000 consecutive
stroke patients identiﬁed obesity as one
signiﬁcant predictor of stroke in women
(mean age 75 years), but not in men (25).
A similar identiﬁcation of obesity as a risk
factor for atherothrombotic brain infarc-
tion in older female but not male subjects
was also reported by Aronow et al. (26).
In a post hoc analysis of the Systolic Hy-
pertension in the Elderly (SHEP) trial, the
lowest BMI quintile was associated with
increased occurrence of stroke rather
than obesity (27), but after introduction
of control of multiple confounders, the
relation of BMI to death or stroke rate in
the placebo group became insigniﬁcant.
Overall, we interpret this mixed outcome
oftheattempttoclarifywhetherobesityis
a contributor to the etiology of stroke in
the elderly as a simple reﬂection of the
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ing obesity-related hypertension, as well
as adiposity-related diabetes in this
setting.
OBESITY MAY BE A
PREDISPOSING FACTOR
FOR REDUCED COGNITIVE
SKILLS AND ALZHEIMER’S
DISEASE— In the otherwise healthy
older population, the combination of an
expansive waist circumference or BMI,
with high systolic or diastolic blood pres-
sure, was linked to a modest decrease in
performance on tests of motor speed,
manual dexterity, and executive function
(28). The Framingham Heart Study com-
prising male participants (age range
55–88years)followedupoveraperiodof
18 years revealed that obesity had an ad-
verse effect on cognitive performance
(29). In a Swedish cohort of nonde-
mented adults who were followed up
from age 70 to 88 years, high body mass
waslinkedtoincreasedpropensityforde-
mentia (30). The association appeared to
be so profound that the risk for Alzhei-
mer’s disease increased by 36% for every
BMI unit at the age of 70 years. In popu-
lation studies, such linkage is subject to
the confounding effect of the natural his-
tory of Alzheimer’s disease often charac-
terizedbyweightloss,whichprecedesthe
diagnosis of this condition (8). A recent
meta-analysis of the literature suggested
the existence of a signiﬁcant U-shaped as-
sociation between BMI and Alzheimer’s
disease. The pooled effects of obesity on
incident Alzheimer’s disease and vascular
dementia revealed a 1.80- and 1.73-fold
increase in risk, which was particularly
evident in studies with long follow-up
(10years)andyoungbaselineage(60
years). Of particular note was the ﬁnding
in all the studies reviewed that weight
gain and large waist circumference, or
skinfold thickness, increased the risk of
dementia (31).
OBESITY, MOBILITY, AND
PHYSICAL INDEPENDENCE
IN OLDER SUBJECTS— Low lev-
els of spontaneous physical activity is a
majorpredictorofadiposetissueaccumu-
lation in humans, and total body move-
ment, most of which is related to
ambulation, is negatively correlated with
fat mass (32).
Physical inactivity, in turn, has rapid
profound effects on skeletal muscle me-
tabolism. Unlike the common association
of obesity with increased lean body mass
and muscle volume in young adults,
obeseolderindividualsoftendevelopsar-
copenia, reﬂected by reduction in lean
body mass. Impaired mobility in older
obese individuals is therefore hardly sur-
prising. A recent study of 2,982 subjects,
aged 70–79 years, followed up for 6.5
years, revealed that high adiposity in-
creased the risk of new-onset mobility
limitation by 40–50% (33). A cross-
sectional study of 92 monozygotic and
104 dizygotic community-living pairs of
twin sisters (aged 63–76 years) reared to-
gether found an inverse association be-
tween adiposity and mobility that was
mostly due to the effect of shared genes
(34). Larger waist circumference was a
powerful predictor of new-onset disabil-
ity 2 years later, associated with a 2.17-
fold increase in the adjusted risk of
mobility disability and a 4.77-fold higher
adjusted risk of agility disability for men
in the highest quintile compared with
those in the lowest quintile (35).
OBESITY AND FRAILTY IN
OLDER AGE— Obesity clearly exac-
erbates the age-related decline in physical
function and causes frailty in older indi-
viduals. Frailty in older obese individuals
may be related to the insulin resistance
and inﬂammation that often accompany
obesity (36). This is reﬂected by self-
reported impairment in activities of daily
living in the older obese individual, limi-
tationsinmobilityanddecreasedphysical
performance (as detailed in the former
segment), increased risk for functional
decline,andahigherrateofnursinghome
admissions (35,37–39). Of particular sig-
niﬁcance in establishing a cause-and-
effect relationship between obesity and
frailty is the recent report that weight loss
andexercisecanamelioratefrailtyinolder
obese adults (40).
OBESITY AND
DEGENERATIVE
OSTEOARTHRITIS IN
ADVANCED SENIOR
YEARS— Increased body mass has a
negative impact on weight-bearing joints,
and knee osteoarthritis is particularly
commoninobesemen(58%)andwomen
(68%) by the age of 65 years (41). The
physical limitation caused by this condi-
tion is widely appreciated, but less atten-
tion is paid to the inevitable impact on
painandchronicoverconsumptionofan-
algesics that often underlie the develop-
ment of drug-resistant hypertension and
incipient nephropathy.
SEXUAL DYSFUNCTION
AND OBESITY IN OLDER
SUBJECTS— A recent study indi-
catedthatcentralobesity,assessedbysev-
eral anthropometric indicators, is
associated with the presence of erectile
dysfunction in men 60 years, but not in
younger men (42). Although age ap-
peared to be the major determinant of
erectile dysfunction in NHANES, obesity
had an independent contributory effect,
increasingtheoddsratioforimpotenceby
1.6 (43). In a cross-sectional analysis of
men 50 years of age in the U.S. Health
Professionals’Study,obesityindependent
of other confounding factors increased
the risk of erectile dysfunction by 30%
(44).
URINARY INCONTINENCE
IN OLDER OBESE
SUBJECTS— Obesity is a recognized
contributing factor to urinary incontinence
in older women and men (45). Although
the precise underlying mechanism(s) is un-
clear, the apparent excessive weight and
pressure applied on the bladder by the in-
creased intra-abdominal fat mass appears
to be a reasonable contributor to this
complication.
OBESITY AND RENAL
DISEASE IN OLDER
SUBJECTS— The prevalence of renal
failure increases with age, and obesity is a
signiﬁcant risk factor for end-stage renal
disease (46). Compiled data from 57 pro-
spective studies clearly links obesity to
mortality of kidney disease, such that
death of renal disease increased progres-
sively with BMI (47). Although age-
speciﬁc trends were not provided, hazard
ratiointhisanalysiswasbasedonsubjects
up to the age of 79 years. A recent report
indicatedthatincreasedwaist-to-hipratio
wasasigniﬁcantandindependentpredic-
tor of chronic renal disease in elderly Tai-
wanese (48). In a cross-sectional study in
African Americans, increasing age and
waist circumference were associated with
increased chronic kidney disease (49).
Collectively, this information suggests
that obesity, particularly abdominal adi-
posity, imparts a negative effect on renal
disease in the older population.
CONCLUSIONS — Obesity per se
continuestocontributetomortalityinad-
vanced years. However, even if mortality
is conceded to be unrelated to obesity at
an older age, the unaffected risk of death
remains, at best, an imperfect descriptive
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years of life. Obese, or overweight, older
subjects with such presumed unimpaired
longevity are nevertheless more likely to
have hypertension and diabetes; develop
coronary artery disease and possibly
stroke; experience erectile dysfunction;
suffer from accelerated loss of cognitive
function, incontinence, frailty, osteoar-
thritis, and functional disability; and are
dependent on others. The clustering of so
many well-deﬁned ailments resulting
from, or associated with, obesity, partic-
ularly in older subjects, is impressive
enough to view obesity as a real primary
disease that requires attention and medi-
cal care.
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